StratDeckBMY

Bristol-Myers Squibb Company

BMY✕
Share

Healthcare · Drug Manufacturers - General · United States

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Price64.10USD
1D+0.72%
Market cap131B
AnalystsBuy24
Next earnings29 Oct
Loading chart…

Trade ideas

BMY isn't in any strategy's Top Picks or Good Opportunities today.

Analysts

ConsensusBuy24
Mean score2.46
Mean target66.42+3.61%
Target range40.00–80.00

Value vs sector peers

#4 of 26 in HealthcareCheap for a reason78
  • Fwd P/E9.888
  • P/B5.941
  • Yield4.0%87
  • P/E14.196
  • Rev growth+5.7%34

Nearest in Healthcare

  1. #2GSK.LGSK plcCheap for a reason82
  2. #3PFEPfizer Inc.Cheap for a reason81
  3. #4BMYBristol-Myers Squibb CompanyCheap for a reason78
  4. #5NOVO-B.CONovo Nordisk A/SCheap for a reason78

Fundamentals

P/E14.1
Forward P/E9.8
Price / book5.87
Dividend yield3.96%
Beta0.23
52-week range42.52–68.6483/100
ADV (USD)511M
Relative volume1.0
10d avg volume7.50M
Revenue growth+5.70%
EPS growth+153.10%

Performance

1D+0.72%
7D-4.07%
1M+0.42%
3M+15.26%
6M+9.68%
YTD+22.85%

In the briefing and the feed

Briefing for 15 Sept

Neither the briefing nor the research feed has named BMY.

Catalysts

Next earnings: 29 Oct

Trade idea history

No trade idea has fired on BMY since the ledger opened.

Get it by email

The board BMY sits on, in one five-minute email every weekday before the New York open and on Saturdays: market strength, the biggest movers, earnings coming up and the names sitting at their 200-day EMA.